申请人:MERCK SHARP & DOHME
公开号:WO2010129208A1
公开(公告)日:2010-11-11
Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: Formula (I); are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
化学式(I)描述的化合物或其药用可接受的盐:化学式(I);是p38的抑制剂,对于治疗炎症如哮喘、慢性阻塞性肺病(COPD)、急性呼吸窘迫综合征(ARDS)、类风湿关节炎、类风湿脊柱炎、骨关节炎、痛风性关节炎和其他关节炎症状;炎症性关节、湿疹、牛皮癣或其他炎症性皮肤病如晒伤;包括结膜炎在内的炎症性眼部疾病;发热、疼痛和其他与炎症相关的症状中有用。